Chronic natriuretic peptide protein therapeutics

by Chen, Horng H, Cataliotti, Alessandro, Burnett, John C
Published 2013

Activation of heme-free soluble guanylate cyclase with cinaciguat has beneficial cardiorenal actions when added to furosemide in experimental heart failure

by Boerrigter, Guido, Costello-Boerrigter, Lisa C, Cataliotti, Alessandro, Stasch, Johannes-Peter, Burnett, John C
Published 2011

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure

by Costello-Boerrigter, Lisa C, Boerrigter, Guido, Mangiafico, Sarah, Cataliotti, Alessandro, Burnett, John C
Published 2011

Effects of long-term proBNP cardiac gene delivery in experimental hypertensive heart disease

by Cataliotti, Alessandro, Tonne, Jason M, Boerrigter, Guido, Mangiafico, Salvatore, Burnett, John C, Ikeda, Yasuhiro
Published 2011

Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction

by Chen, Horng H, Cataliotti, Alessandro, Martin, Fernando L, Schirger, John A, Burnett, John C
Published 2009

Mutation of three amino acids in the disulfide-ring of a CNP based chimeric natriuretic peptide alters its vascular properties

by Chen, Horng H, Huntley, Brenda K, Cataliotti, Alessandro, Martin, Fernando L, Burnett, John C
Published 2009

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics

by McKie, Paul M., Cataliotti, Alessandro, Ichiki, Tomoko, Sangaralingham, S. Jeson, Chen, Horng H., Burnett, John C.
Published 2014

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics

by McKie, Paul M, Cataliotti, Alessandro, Ichiki, Tomoko, Sangaralingham, S Jeson, Chen, Horng H, Burnett, John C
Published 2013

Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease

by Tonne, Jason M., Holditch, Sara J., Oehler, Elise A, Schreiber, Claire A., Ikeda, Yasuhiro, Cataliotti, Alessandro
Published 2014

The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation

by Schirger, John A, Chen, Horng H, Slusser, Josh, Hodge, David, Heublein, Denise, Cataliotti, Alessandro, Sandberg, Sharon, Burnett, John C
Published 2009

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging

by Sangaralingham, Jeson S, Heublein, Denise M, Grande, Joseph P, Cataliotti, Alessandro, Rule, Andrew D, McKie, Paul M, Martin, Fernando L, Burnett, John C
Published 2011

Pro-B-Type natriuretic peptide: a novel, specific biomarker for detection of left ventricular dysfunction in the general community

by Macheret, Fima, Heublein, Denise, Lahr, Brian, Costello-Boerrigter, Lisa, Boerrigter, Guido, McKie, Paul, Sandberg, Sharon, Rodeheffer, Richard, Cataliotti, Alessandro, Burnett, John C
Published 2009

Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study

by Bellavia, Diego, Cataliotti, Alessandro, Clemenza, Francesco, Baravoglia, Cesar Hernandez, Luca, Angelo, Traina, Marcello, Gridelli, Bruno, Bertani, Tullio, Burnett, John C., Scardulla, Cesare
Published 2015